Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer crawled time : 12:15 save search
Celyad Oncology Presents Preclinical Data on Allogeneic CAR T Therapy Program and Highlights KEYNOTE-B79 Clinical Trial Design at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-11-12 (Crawled : 12:15) - celyad.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
immunotherapy therapy cancer trial car-t preclinical pre-clinical designation
Neoadjuvant Opdivo (nivolumab) Plus Chemotherapy Significantly Improves Event-Free Survival in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial
Published: 2021-11-08 (Crawled : 12:15) - biospace.com/
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
lung cancer therapy cancer phase 3 trial nivolumab
XOMA Earns $35 Million Milestone Payment as Anti-TGFβ Antibody Enters Phase 3 Clinical Study in Metastatic Pancreatic Cancer
Published: 2021-11-04 (Crawled : 12:15) - biospace.com/
XOMA | News | $24.97 1.55% 1.52% 17K
|
Health Technology
|
| O: -1.02%
H: 4.27%
C: 0.79%
cancer antibody phase 3 pancreatic pancreas milestone
Alkermes to Present Data on Nemvaleukin Alfa at the Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting
Published: 2021-11-03 (Crawled : 12:15) - biospace.com/
ALKS | $23.86 0.42% 0.42% 2.4M
|
Health Technology
|
| O: -2.41%
H: 3.58%
C: 3.48%
immunotherapy therapy cancer nemvaleukin
Immatics to Present Update on Lead ACTengine® Program IMA203 Targeting PRAME at the Society for Immunotherapy of Cancer’s 36th Annual Meeting
Published: 2021-11-01 (Crawled : 12:15) - immatics.com
IMTX | $10.19 -0.68% -0.69% 180K
|
Health Technology
|
| O: 1.95%
H: 1.98%
C: -1.57%
immunotherapy therapy cancer ima203
HCW Biologics Receives FDA Clearance to Proceed with Phase 1b Clinical Trial for Immunotherapeutic HCW9218 for Pancreatic Cancer
Published: 2021-10-28 (Crawled : 12:15) - biospace.com/
HCWB | $1.66 0.0% 1.4K
|
|
| O: 60.62%
H: 50.32%
C: 0.85%
fda clearance fda phase 1 cancer phase 1b trial pancreatic hcw9218 pancreas phase 2b clearance
Werewolf Therapeutics to Present Data on its INDUKINE™ Product Candidates at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-10-27 (Crawled : 12:15) - biospace.com/
HOWL | $5.91 0.68% 0.68% 120K
|
Professional, Scientific, and T...
|
| O: -1.04%
H: 3.94%
C: 1.64%
immunotherapy therapy cancer
Adagene Establishes Collaboration for Clinical Trial of ADG106 in Combination with Nivolumab in Patients with Non-Small Cell Lung Cancer in Singapore
Published: 2021-10-27 (Crawled : 12:15) - biospace.com/
ADAG | $2.63 -0.38% -0.38% 5.4K
|
Manufacturing
| Email alert
Add to watchlist
lung cancer collaboration cancer trial nivolumab
Bionano Genomics Announces American Society of Human Genetics Presentations Featuring Optical Genome Mapping for Genetic Disease and Cancer Research Applications
Published: 2021-10-15 (Crawled : 12:15) - globenewswire.com
BNGO | $0.75 -4.73% -4.96% 980K
|
Health Technology
|
| O: 1.31%
H: 0.18%
C: -4.62%
presentation disease genetic optical application genomic cancer research
Bio-Techne Announces ExoDx Prostate Test Data Publication in the Journal of Prostate Cancer and Prostatic Diseases
Published: 2021-10-13 (Crawled : 12:15) - biospace.com/
TECH | $62.12 -0.15% -0.14% 910K
|
Health Technology
|
| O: 0.91%
H: 0.19%
C: 0.13%
disease prostate cancer test cancer
Editas Medicine to Present Preclinical Data on Novel Engineered iPSC Derived NK Cells for the Treatment of Cancer at the Society for Immunotherapy of Cancer 36th Annual Meeting
Published: 2021-10-07 (Crawled : 12:15) - globenewswire.com
EDIT | $5.5 -0.9% -0.91% 2.3M
|
Health Technology
|
| O: 0.99%
H: 5.99%
C: 2.95%
treatment immunotherapy therapy cancer preclinical pre-clinical
Harpoon Therapeutics to Present Preclinical Data on its TriTAC-XR Platform at the 36th Annual Meeting of the Society for Immunotherapy of Cancer
Published: 2021-10-05 (Crawled : 12:15) - biospace.com/
HARP | $23.01 0.07% 6.6M
|
Health Technology
|
| O: 0.75%
H: 1.48%
C: 0.2%
immunotherapy therapy cancer preclinical pre-clinical
Poseida Therapeutics to Present at Society for Immunotherapy of Cancer 2021 Annual Meeting
Published: 2021-10-01 (Crawled : 12:15) - prnewswire.com
PSTX | News | $2.02 1.0% 0.99% 640K
|
Health Technology
|
| O: -0.69%
H: 0.0%
C: -2.62%
immunotherapy therapy cancer
Celyad Oncology to Present New Data on Allogeneic CAR T Therapy Program at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-10-01 (Crawled : 12:15) - celyad.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: 3.66%
H: 0.0%
C: -4.47%
immunotherapy therapy cancer car-t
Genmab Announces Abstracts Evaluating Investigational Solid Tumor Therapies to be Presented at the Society for Immunotherapy of Cancer’s 36th Annual Meeting (SITC 2021)
Published: 2021-10-01 (Crawled : 12:15) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: 3.86%
H: 0.57%
C: 0.57%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -1.01%
H: 0.42%
C: -0.23%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -8.06%
H: 3.28%
C: 1.51%
immunotherapy therapy cancer solid tumors
aTyr Pharma Announces Poster Presentation at the Society for Immunotherapy of Cancer Annual Meeting
Published: 2021-10-01 (Crawled : 12:15) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: -0.55%
H: 0.74%
C: -5.2%
presentation immunotherapy therapy cancer pharma
Fate Therapeutics Announces Presentations at the Society for Immunotherapy of Cancer 2021 Annual Meeting
Published: 2021-10-01 (Crawled : 12:15) - globenewswire.com
FATE | $4.795 -4.86% -5.11% 2.7M
|
Health Technology
|
| O: 0.66%
H: 1.36%
C: -0.27%
presentation immunotherapy therapy cancer
Replimune Announces Presentations at the 2021 Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Published: 2021-10-01 (Crawled : 12:15) - globenewswire.com
REPL | $6.47 -7.17% -7.73% 870K
|
Health Technology
|
| O: 0.81%
H: 0.0%
C: -1.1%
presentation immunotherapy therapy cancer
Affimed Announces Acceptance of Three Abstracts with Preclinical Data on Its Innate Cell Engagers at the 36th Annual Meeting of the Society for Immunotherapy of Cancer
Published: 2021-10-01 (Crawled : 12:15) - globenewswire.com
AFMD | $5.15 1.58% 1.55% 64K
|
Health Technology
|
| O: 1.29%
H: 0.16%
C: -1.6%
immunotherapy therapy cancer preclinical pre-clinical
Sensei Biotherapeutics to Present New Preclinical Data for SNS-101, a Proprietary Anti-VISTA Antibody, at the 36th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Published: 2021-10-01 (Crawled : 12:15) - globenewswire.com
SNSE | $1.03 4.79% 4.57% 24K
|
|
| O: -0.67%
H: 2.39%
C: 0.29%
immunotherapy therapy cancer antibody iot preclinical pre-clinical
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.